PharmiWeb Solutions

PharmiWeb Solutions | February 08, 2017

PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that an audio recording of the company’s shareholder call, which was held on February 7, 2017, by the Chief Executive Officer of PharmaCyte, Kenneth L. Waggoner, is now available for playback. PharmaCyte also announced that the remaining unanswered questions and answers have be...

PharmiWeb Solutions | February 08, 2017

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer and other hypoxia-related diseases, today announced that the data from the Phase 1/2 clinical trial evaluating the safety and efficacy of trans sodium crocetinate (TSC) in newly diagnosed glioblastoma multiforme (GBM) has been published in the print edition of the peer-reviewed Journal of Neurosurgery (“JNS”) (Volume 126, February 2017). ...

PharmiWeb Solutions | February 08, 2017

Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that the U.S. Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) has informed the Company, as part of its mid-cycle review, that it does not plan to hold an Advisory Committee meeting for Portola’s New Drug Application (NDA) for betrixaban. Betrixaban is an oral, once-daily Factor Xa inhibitor anticoagulant. The NDA for betrixaban, an FDA Fast Track-designated therapy, is under priority review by the FD...

PharmiWeb Solutions | February 08, 2017

Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced that its President and Chief Operating Officer, Evan Loh, MD, will participate in the LEERINK Partners 6th Annual Global Healthcare Conference on Wednesday, February 15 with a fireside chat from 1:00 to 1:25 p.m. The conference is being held at the at the Lotte New York Palace Hotel in New York, New York. Paratek is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycli...